Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4 - PubMed (original) (raw)
. 1993 Nov 15;268(32):23906-14.
Affiliations
- PMID: 7693696
Free article
Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4
S Guimond et al. J Biol Chem. 1993.
Free article
Abstract
Chlorate-treated Swiss 3T3 fibroblasts, with impaired synthesis of heparan sulfate proteoglycan, were used as target cells in assessing the ability of exogenous heparin-derived saccharides to promote the mitogenic activity of basic fibroblast growth factor 2 (FGF-2). Full-size native heparin (carrying iduronosyl 2-O-sulfate and glucosaminyl 6-O-sulfate groups), as well as a dodecasaccharide fraction isolated after limited deaminative cleavage of heparin, were efficient promoters, whereas the corresponding decasaccharides, or smaller oligosaccharides, were inactive. Neither selectively 2-O-desulfated nor preferentially 6-O-desulfated heparin were active. However, the latter derivative competed with native heparin for binding to FGF-2 and thus blocked the ability of native heparin to promote the mitogenic activity of FGF-2. The 6-O-desulfated heparin also prevented the ability of FGF-2 to suppress myogenic differentiation in MM14 mouse myoblasts. The binding region for FGF-2 has been identified as a pentasaccharide sequence containing a single essential O-sulfate group, at C2 of iduronic acid (1). It is proposed that the dodecasaccharide sequence required to promote receptor signaling by FGF-2 encompasses this pentasaccharide region, which binds the growth factor, and a site interacting with the receptor that contains essential 2-O- and 6-O-sulfate groups. Similar studies involving the related growth factors, FGF-1 and FGF-4, revealed differential effects of saccharides. The mitogenic effect induced by FGF-1 thus was not blocked by either the 2-O- or the 6-O-desulfated heparins. However, both of these derivatives, at high concentrations, promote mitogenic activity of FGF-4. It is concluded that specific saccharide sequences within heparan sulfate glycosaminoglycan chains favor the signaling by distinct members of the FGF family.
Similar articles
- Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M, Casu B, Lindahl U. Maccarana M, et al. J Biol Chem. 1993 Nov 15;268(32):23898-905. J Biol Chem. 1993. PMID: 8226930 - Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
Ishihara M. Ishihara M. Glycobiology. 1994 Dec;4(6):817-24. doi: 10.1093/glycob/4.6.817. Glycobiology. 1994. PMID: 7537556 - Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
Olwin BB, Rapraeger A. Olwin BB, et al. J Cell Biol. 1992 Aug;118(3):631-9. doi: 10.1083/jcb.118.3.631. J Cell Biol. 1992. PMID: 1379245 Free PMC article. - Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M, Guerrini M, Bisio A, Torri G, Naggi A, Casu B. Hricovíni M, et al. Semin Thromb Hemost. 2002 Aug;28(4):325-34. doi: 10.1055/s-2002-34301. Semin Thromb Hemost. 2002. PMID: 12244479 Review. - Diversity does make a difference: fibroblast growth factor-heparin interactions.
Faham S, Linhardt RJ, Rees DC. Faham S, et al. Curr Opin Struct Biol. 1998 Oct;8(5):578-86. doi: 10.1016/s0959-440x(98)80147-4. Curr Opin Struct Biol. 1998. PMID: 9818261 Review.
Cited by
- The fibroblast growth factor-Klotho axis at molecular level.
Sun F, Liang P, Wang B, Liu W. Sun F, et al. Open Life Sci. 2023 Oct 27;18(1):20220655. doi: 10.1515/biol-2022-0655. eCollection 2023. Open Life Sci. 2023. PMID: 37941788 Free PMC article. Review. - Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharide libraries for decoding glycosaminoglycan-protein interactions.
Wang L, Sorum AW, Huang BS, Kern MK, Su G, Pawar N, Huang X, Liu J, Pohl NLB, Hsieh-Wilson LC. Wang L, et al. Nat Chem. 2023 Aug;15(8):1108-1117. doi: 10.1038/s41557-023-01248-4. Epub 2023 Jun 22. Nat Chem. 2023. PMID: 37349377 Free PMC article. - Heparan sulfate glycomimetics via iterative assembly of "clickable" disaccharides.
Yang C, Deng Y, Wang Y, Xia C, Mehta AY, Baker KJ, Samal A, Booneimsri P, Lertmaneedang C, Hwang S, Flynn JP, Cao M, Liu C, Zhu AC, Cummings RD, Lin C, Mohanty U, Niu J. Yang C, et al. Chem Sci. 2023 Feb 28;14(13):3514-3522. doi: 10.1039/d3sc00260h. eCollection 2023 Mar 29. Chem Sci. 2023. PMID: 37006675 Free PMC article. - Synthesis of a Systematic 64-Membered Heparan Sulfate Tetrasaccharide Library.
Baryal KN, Ramadan S, Su G, Huo C, Zhao Y, Liu J, Hsieh-Wilson LC, Huang X. Baryal KN, et al. Angew Chem Int Ed Engl. 2023 Jan 2;62(1):e202211985. doi: 10.1002/anie.202211985. Epub 2022 Dec 1. Angew Chem Int Ed Engl. 2023. PMID: 36173931 Free PMC article. - Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function.
Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Pretorius D, et al. Matrix Biol Plus. 2022 Sep 7;16:100121. doi: 10.1016/j.mbplus.2022.100121. eCollection 2022 Dec. Matrix Biol Plus. 2022. PMID: 36160687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous